Corbus Pharmaceuticals Holdings, Inc. (CRBP)
PHARMACEUTICAL PREPARATIONS
Corbus Pharmaceuticals Holdings, Inc. (CRBP) is listed on Nasdaq, where it has traded since October 24, 2014.
- Listed On
- Nasdaq
- Listed Since
- October 24, 2014
- Employees
- 36
- Market Cap
- $138M
About Corbus Pharmaceuticals Holdings, Inc.
Corbus Pharmaceuticals Holdings Inc is a clinical stage company focused on new therapies in oncology and obesity and is committed to helping people defeat serious illness by bringing inventive scientific approaches to well-understood biological pathways. The company's development pipeline includes; CRB-701, a next-generation antibody-drug conjugate (ADC) that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload, CRB-601, an anti-integrin monoclonal antibody that blocks the activation of TGF expressed on cancer cells, and CRB-913 a second-generation peripherally restricted CB1 receptor inverse agonist designed to treat obesity.
Institutional ownership
In 13F filings for the quarter ended June 30, 2026, 102 institutions reported holding CRBP, with 13.8 million shares worth $129.1 million in aggregate. The largest reported holder was Cormorant Asset Management, with 2.3 million shares worth $22.0 million. Of the 5 largest holders listed below, 2 added shares and 3 held their positions unchanged during the quarter.
| Institution | Shares | Value | Quarter change |
|---|---|---|---|
| Cormorant Asset Management | 2,344,971 | $22M | Unchanged |
| Orbimed Advisors | 1,737,287 | $16M | Unchanged |
| BlackRock | 1,331,135 | $12M | Added 390.04% |
| Aberdeen Group | 1,321,750 | $12M | Unchanged |
| Vanguard | 989,334 | $9M | Added 15.12% |
Form 13F is a quarterly report that institutional investment managers with at least $100 million in qualifying securities file with the SEC. It lists long positions as of the last day of the quarter and is due within 45 days of quarter end, so these holdings describe that date rather than today.
Frequently asked questions
What is CRBP?
Corbus Pharmaceuticals Holdings, Inc. (CRBP) is listed on Nasdaq, where it has traded since October 24, 2014.
Who are the largest institutional holders of CRBP?
In 13F filings for the quarter ended June 30, 2026, the largest reported holders of CRBP were Cormorant Asset Management, Orbimed Advisors and BlackRock.
How many institutions own CRBP?
102 institutions reported a position in CRBP for the quarter ended June 30, 2026, worth $129.1 million in total.
Did institutions buy or sell CRBP last quarter?
Of the 5 largest reported holders, 2 added shares and 3 held their positions unchanged during the quarter. Every reported holder and its change is on the SentiSense ownership page for CRBP.
Every reported institutional holder, plus insider and congressional trades in CRBP, on SentiSense.